泰坦智華科技(00872.HK)委任核數師 料明年1月底前刊發2021年業績
泰坦智華科技(00872.HK)公布,國衛已辭任核數師,自10月14日起生效。另委任先機為核數師,自上周五(18日)起生效,任期至下屆股東周年大會結束。
根據公司與先機的討論,倘若並無不可預見的情況,公司預計將於明年1月底之前刊發2021年經審核年度業績及2021年年報。截至2022年6月底止六個月財務業績的編製將相應延遲,而2022年中期業績及2022年中期報告預計將於明年3月底或之前刊發及寄發。
公司股份自今年7月18日起停牌,並將續停牌以待履行復牌指引。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.